跳至主要内容
临床试验/ACTRN12623000700639
ACTRN12623000700639招募中Unknown

Determining the Minimally Important Difference (MID) for Exertional Breathlessness measured using the Dyspnea Challenge in the COPD and Heart Failure populations.

Professor Norman Morris0 个研究点目标入组 30 人开始时间: 2023年6月30日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. A known diagnosis of COPD (GOLD I – IV) or Heart Failure (NYHA I – IV).
  • 2. Clinically stable and/or on stable, optimized therapy for two weeks prior to enrolment for COPD patients and six weeks for heart failure patients.

排除标准

  • 1. Significant co-morbidities that would exclude exertional exercise or any contraindications to exercise as outlined by the American College of Sports Medicine (ACSM's Guidelines for Exercise Testing and Prescription, Eighth Edition, 2010, Wolters Kluwer/LIppincott Williams and Wilkins. Philadelphia, USA)
  • 2. Inability to walk on a treadmill

研究者

发起方
Professor Norman Morris

相似试验